WilmerHale Advises Autobahn Labs in Drug Discovery Collaboration with UCSF

• 12.21.2020

On December 21, 2020, Autobahn Labs, a virtual incubator partnering with top academic and research institutions to catalyze early-stage drug discovery and development, announced a strategic collaboration with the University of California San Francisco (UCSF). The organizations will partner to identify promising early science with significant therapeutic potential, forming jointly owned ventures to accelerate the translation of scientific ideas to novel therapeutics. The collaboration with UCSF is the second partnership announced by Autobahn Labs since the organization’s launch in June 2020, and expands the reach of the innovative partnership between Samsara BioCapital and Evotec.

The WilmerHale team representing Autobahn Labs includes Jason Kropp, Jenna Ventorino and Ryan Crane.